The biochemical differentiation profile of neuroblastoma cells overexpressing TMODs showed a significant increase of MAP2 and GAP43, mimicking then the “neuronal differentiation” obtained by retinoic acid, and an overall decrease of TH, DBH and CgA mRNA expression levels. The gene discussed is MAP2; the disease is neuroblastoma.